Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00002961
What this trial is testing

Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Hospital of Philadelphia 43
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Looking for participantsNCT06374459
What this trial is testing

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Who this might be right for
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
Washington University School of Medicine 152
Testing effectiveness (Phase 2)Study completedNCT00006373
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT03952039
What this trial is testing

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraMyelofibrosis
Celgene 202
Early research (Phase 1)Study completedNCT01582295
What this trial is testing

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 4
Not applicableUnknownNCT02869256
What this trial is testing

Regional Central Database Recording of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Institut Bergonié 400
Testing effectiveness (Phase 2)Study completedNCT00003745
What this trial is testing

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 125
Early research (Phase 1)Study completedNCT01154439
What this trial is testing

Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 11
Not applicableStudy completedNCT03330301
What this trial is testing

D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life

Who this might be right for
Vitamin D DeficiencyObesityDiabetes Mellitus+11 more
Bispebjerg Hospital 222,776
Not applicableUnknownNCT06231628
What this trial is testing

Imaging Guided Cementoplasty for Pelvic Bone Metastasis

Who this might be right for
Imaging GuidedPercutaneous CementoplastyPelvic Bone Metstasis
Assiut University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Early research (Phase 1)Ended earlyNCT01085656
What this trial is testing

A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

Who this might be right for
Leukemia, Myelogenous, AcuteMyelodysplastic Syndromes
University of Florida 18
Not applicableUnknownNCT06177366
What this trial is testing

A New Blood Score for Myelofibrosis Staging

Who this might be right for
Myeloproliferative Neoplasm
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Study completedNCT01987102
What this trial is testing

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Who this might be right for
Osteosarcoma
Isofol Medical AB 18
Testing effectiveness (Phase 2)Study completedNCT00889057
What this trial is testing

Sorafenib in Relapsed High Grade Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 35
Not applicableStudy completedNCT07471022
What this trial is testing

Hemiarthroplasty for Elderly With Proximal Humeral Mets

Who this might be right for
Bone Metastases of a Malignant TumorMetastatic Bone Tumor
Sichuan Provincial People's Hospital 53
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Next Page